Pharmaceutical vs. Supplement Pre-Market Requirements¶
Specification¶
The full specification below is extracted from Chapter 20: "Health Fraud, Nutritional Misinformation, and the Supplement Industry".
Type: microsim
**sim-id:** dshea-regulatory-gap<br/>
**Library:** p5.js<br/>
**Status:** Specified
Side-by-side interactive comparison diagram. Left panel: "Pharmaceutical Drug Path to Market" — vertical flowchart with clickable steps: Preclinical Research → Phase I Safety Trial → Phase II Efficacy Trial → Phase III Large-Scale Trial → FDA NDA Review → Approval → Post-Market Surveillance. Each step shows typical cost range and duration. Right panel: "Dietary Supplement Path to Market" — vertical flowchart with clickable steps: Formulate Product → Manufacturer Self-Certifies Safety → Submit 75-Day New Dietary Ingredient Notification (if new ingredient only) → Market Product → FDA Monitors Post-Market Complaints. Steps that are required for drugs but not supplements are highlighted in orange with label "NOT REQUIRED for supplements." Clicking any step on either side shows a popup with 2–3 sentences describing what that step involves and what protection it provides (or what gap exists). Bottom panel shows a comparison summary: average drug approval timeline (~12 years), average supplement time to market (~months). Canvas: 800×480px.